Entropy Technologies’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,916
Closed -$724K 954
2025
Q4
$724K Buy
+10,916
New +$706K 0.04% 466
2024
Q4
Sell
-51,914
Closed -$3.48M 800
2024
Q3
$3.48M Buy
+51,914
New +$4.26M 0.37% 73
2024
Q2
Sell
-15,228
Closed -$2.11M 745
2024
Q1
$2.11M Buy
+15,228
New +$1.91M 0.23% 137

Other funds holding DXCM

Entropy Technologies's DXCM Position: Q1 2026 in Review

Entropy Technologies sold out of DexCom (DXCM) in Q1 2026, closing a stake of 10,916 shares — an estimated $724K sold.

Entropy Technologies first reported a position in DXCM in Q1 2024 and held it in 3 quarters. The position peaked at $3.48M in Q3 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Entropy Technologies reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Entropy Technologies sold 10,916 DexCom shares in Q1 2026, an estimated $724K.
  • Entropy Technologies first reported a position in DexCom in Q1 2024 and held it in 3 quarters.
  • Entropy Technologies's DexCom position peaked at $3.48M in Q3 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Entropy Technologies's 13F filing for Q1 2026, filed 14 May 2026.